Literature DB >> 27698005

Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.

Merlise A Clyde, Rachel Palmieri Weber, Edwin S Iversen, Elizabeth M Poole, Jennifer A Doherty, Marc T Goodman, Roberta B Ness, Harvey A Risch, Mary Anne Rossing, Kathryn L Terry, Nicolas Wentzensen, Alice S Whittemore, Hoda Anton-Culver, Elisa V Bandera, Andrew Berchuck, Michael E Carney, Daniel W Cramer, Julie M Cunningham, Kara L Cushing-Haugen, Robert P Edwards, Brooke L Fridley, Ellen L Goode, Galina Lurie, Valerie McGuire, Francesmary Modugno, Kirsten B Moysich, Sara H Olson, Celeste Leigh Pearce, Malcolm C Pike, Joseph H Rothstein, Thomas A Sellers, Weiva Sieh, Daniel Stram, Pamela J Thompson, Robert A Vierkant, Kristine G Wicklund, Anna H Wu, Argyrios Ziogas, Shelley S Tworoger, Joellen M Schildkraut.   

Abstract

Previously developed models for predicting absolute risk of invasive epithelial ovarian cancer have included a limited number of risk factors and have had low discriminatory power (area under the receiver operating characteristic curve (AUC) < 0.60). Because of this, we developed and internally validated a relative risk prediction model that incorporates 17 established epidemiologic risk factors and 17 genome-wide significant single nucleotide polymorphisms (SNPs) using data from 11 case-control studies in the United States (5,793 cases; 9,512 controls) from the Ovarian Cancer Association Consortium (data accrued from 1992 to 2010). We developed a hierarchical logistic regression model for predicting case-control status that included imputation of missing data. We randomly divided the data into an 80% training sample and used the remaining 20% for model evaluation. The AUC for the full model was 0.664. A reduced model without SNPs performed similarly (AUC = 0.649). Both models performed better than a baseline model that included age and study site only (AUC = 0.563). The best predictive power was obtained in the full model among women younger than 50 years of age (AUC = 0.714); however, the addition of SNPs increased the AUC the most for women older than 50 years of age (AUC = 0.638 vs. 0.616). Adapting this improved model to estimate absolute risk and evaluating it in prospective data sets is warranted.
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  genetic risk polymorphisms; model evaluation; ovarian cancer; risk model

Mesh:

Year:  2016        PMID: 27698005      PMCID: PMC5065620          DOI: 10.1093/aje/kww091

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  58 in total

1.  Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

Authors:  V McGuire; A Felberg; M Mills; K L Ostrow; R DiCioccio; E M John; D W West; A S Whittemore
Journal:  Am J Epidemiol       Date:  2004-10-01       Impact factor: 4.897

2.  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

Authors:  Ellen L Goode; Georgia Chenevix-Trench; Honglin Song; Susan J Ramus; Maria Notaridou; Kate Lawrenson; Martin Widschwendter; Robert A Vierkant; Melissa C Larson; Susanne K Kjaer; Michael J Birrer; Andrew Berchuck; Joellen Schildkraut; Ian Tomlinson; Lambertus A Kiemeney; Linda S Cook; Jacek Gronwald; Montserrat Garcia-Closas; Martin E Gore; Ian Campbell; Alice S Whittemore; Rebecca Sutphen; Catherine Phelan; Hoda Anton-Culver; Celeste Leigh Pearce; Diether Lambrechts; Mary Anne Rossing; Jenny Chang-Claude; Kirsten B Moysich; Marc T Goodman; Thilo Dörk; Heli Nevanlinna; Roberta B Ness; Thorunn Rafnar; Claus Hogdall; Estrid Hogdall; Brooke L Fridley; Julie M Cunningham; Weiva Sieh; Valerie McGuire; Andrew K Godwin; Daniel W Cramer; Dena Hernandez; Douglas Levine; Karen Lu; Edwin S Iversen; Rachel T Palmieri; Richard Houlston; Anne M van Altena; Katja K H Aben; Leon F A G Massuger; Angela Brooks-Wilson; Linda E Kelemen; Nhu D Le; Anna Jakubowska; Jan Lubinski; Krzysztof Medrek; Anne Stafford; Douglas F Easton; Jonathan Tyrer; Kelly L Bolton; Patricia Harrington; Diana Eccles; Ann Chen; Ashley N Molina; Barbara N Davila; Hector Arango; Ya-Yu Tsai; Zhihua Chen; Harvey A Risch; John McLaughlin; Steven A Narod; Argyrios Ziogas; Wendy Brewster; Aleksandra Gentry-Maharaj; Usha Menon; Anna H Wu; Daniel O Stram; Malcolm C Pike; Jonathan Beesley; Penelope M Webb; Xiaoqing Chen; Arif B Ekici; Falk C Thiel; Matthias W Beckmann; Hannah Yang; Nicolas Wentzensen; Jolanta Lissowska; Peter A Fasching; Evelyn Despierre; Frederic Amant; Ignace Vergote; Jennifer Doherty; Rebecca Hein; Shan Wang-Gohrke; Galina Lurie; Michael E Carney; Pamela J Thompson; Ingo Runnebaum; Peter Hillemanns; Matthias Dürst; Natalia Antonenkova; Natalia Bogdanova; Arto Leminen; Ralf Butzow; Tuomas Heikkinen; Kari Stefansson; Patrick Sulem; Sören Besenbacher; Thomas A Sellers; Simon A Gayther; Paul D P Pharoah
Journal:  Nat Genet       Date:  2010-09-19       Impact factor: 38.330

3.  Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy.

Authors:  Allison F Vitonis; Linda Titus-Ernstoff; Daniel W Cramer
Journal:  Obstet Gynecol       Date:  2011-05       Impact factor: 7.661

4.  Parity, age at first childbirth, and risk of ovarian cancer.

Authors:  H O Adami; C C Hsieh; M Lambe; D Trichopoulos; D Leon; I Persson; A Ekbom; P O Janson
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

5.  Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship.

Authors:  J M Schildkraut; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

6.  Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Authors:  Weiva Sieh; Shannon Salvador; Valerie McGuire; Rachel Palmieri Weber; Kathryn L Terry; Mary Anne Rossing; Harvey Risch; Anna H Wu; Penelope M Webb; Kirsten Moysich; Jennifer A Doherty; Anna Felberg; Dianne Miller; Susan J Jordan; Marc T Goodman; Galina Lurie; Jenny Chang-Claude; Anja Rudolph; Susanne Krüger Kjær; Allan Jensen; Estrid Høgdall; Elisa V Bandera; Sara H Olson; Melony G King; Lorna Rodriguez-Rodriguez; Lambertus A Kiemeney; Tamara Marees; Leon F Massuger; Anne M van Altena; Roberta B Ness; Daniel W Cramer; Malcolm C Pike; Celeste Leigh Pearce; Andrew Berchuck; Joellen M Schildkraut; Alice S Whittemore
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

7.  Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.

Authors:  Jeffrey A Tice; Steven R Cummings; Rebecca Smith-Bindman; Laura Ichikawa; William E Barlow; Karla Kerlikowske
Journal:  Ann Intern Med       Date:  2008-03-04       Impact factor: 25.391

8.  Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers.

Authors:  Ju-Hyun Park; Mitchell H Gail; Mark H Greene; Nilanjan Chatterjee
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

9.  Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Authors:  Britton Trabert; Roberta B Ness; Wei-Hsuan Lo-Ciganic; Megan A Murphy; Ellen L Goode; Elizabeth M Poole; Louise A Brinton; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Galina Lurie; Susanne K Kjær; Estrid Hogdall; Allan Jensen; Daniel W Cramer; Kathryn L Terry; Allison Vitonis; Elisa V Bandera; Sara Olson; Melony G King; Urmila Chandran; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Anna H Wu; Celeste Leigh Pearce; Malcolm C Pike; Andrew Berchuck; Joellen M Schildkraut; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 11.816

10.  BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.

Authors:  A J Lee; A P Cunningham; K B Kuchenbaecker; N Mavaddat; D F Easton; A C Antoniou
Journal:  Br J Cancer       Date:  2013-12-17       Impact factor: 7.640

View more
  10 in total

1.  RE: "RISK PREDICTION FOR EPITHELIAL OVARIAN CANCER IN 11 UNITED STATES-BASED CASE-CONTROL STUDIES: INCORPORATION OF EPIDEMIOLOGIC RISK FACTORS AND 17 CONFIRMED GENETIC LOCI".

Authors: 
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

2.  Posttraumatic Stress Disorder Is Associated with Increased Risk of Ovarian Cancer: A Prospective and Retrospective Longitudinal Cohort Study.

Authors:  Laura D Kubzansky; Shelley S Tworoger; Andrea L Roberts; Tianyi Huang; Karestan C Koenen; Yongjoo Kim
Journal:  Cancer Res       Date:  2019-09-05       Impact factor: 12.701

Review 3.  Ovarian cancer epidemiology in the era of collaborative team science.

Authors:  Rikki A Cannioto; Britton Trabert; Elizabeth M Poole; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2017-03-10       Impact factor: 2.506

4.  Epidemiologic paradigms for progress in ovarian cancer research.

Authors:  Shelley S Tworoger; Jennifer Anne Doherty
Journal:  Cancer Causes Control       Date:  2017-05       Impact factor: 2.506

5.  Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors.

Authors:  Andrew Lee; Xin Yang; Jonathan Tyrer; Aleksandra Gentry-Maharaj; Andy Ryan; Nasim Mavaddat; Alex P Cunningham; Tim Carver; Stephanie Archer; Goska Leslie; Jatinder Kalsi; Faiza Gaba; Ranjit Manchanda; Simon Gayther; Susan J Ramus; Fiona M Walter; Marc Tischkowitz; Ian Jacobs; Usha Menon; Douglas F Easton; Paul Pharoah; Antonis C Antoniou
Journal:  J Med Genet       Date:  2021-11-29       Impact factor: 5.941

Review 6.  Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research.

Authors:  Jennifer A Doherty; Allan Jensen; Linda E Kelemen; Celeste L Pearce; Elizabeth Poole; Joellen M Schildkraut; Kathryn L Terry; Shelley S Tworoger; Penelope M Webb; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2017-10-01       Impact factor: 13.506

7.  Epidemiology of ovarian cancer: a review.

Authors:  Brett M Reid; Jennifer B Permuth; Thomas A Sellers
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

8.  Cancer Loyalty Card Study (CLOCS): protocol for an observational case-control study focusing on the patient interval in ovarian cancer diagnosis.

Authors:  Hannah R Brewer; Yasemin Hirst; Sudha Sundar; Marc Chadeau-Hyam; James M Flanagan
Journal:  BMJ Open       Date:  2020-09-08       Impact factor: 2.692

9.  The DNA methylome of cervical cells can predict the presence of ovarian cancer.

Authors:  James E Barrett; Allison Jones; Iona Evans; Daniel Reisel; Chiara Herzog; Kantaraja Chindera; Mark Kristiansen; Olivia C Leavy; Ranjit Manchanda; Line Bjørge; Michal Zikan; David Cibula; Martin Widschwendter
Journal:  Nat Commun       Date:  2022-02-01       Impact factor: 14.919

10.  Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.

Authors:  Jing Dong; Matthew F Buas; Puya Gharahkhani; Bradley J Kendall; Lynn Onstad; Shanshan Zhao; Lesley A Anderson; Anna H Wu; Weimin Ye; Nigel C Bird; Leslie Bernstein; Wong-Ho Chow; Marilie D Gammon; Geoffrey Liu; Carlos Caldas; Paul D Pharoah; Harvey A Risch; Prasad G Iyer; Brian J Reid; Laura J Hardie; Jesper Lagergren; Nicholas J Shaheen; Douglas A Corley; Rebecca C Fitzgerald; David C Whiteman; Thomas L Vaughan; Aaron P Thrift
Journal:  Gastroenterology       Date:  2017-12-13       Impact factor: 22.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.